Bleeding stroke drug trial aims to stop brain bleed fast
Disease control
Recruiting now
This study tests a drug called rFVIIa that helps blood clot, given within 2 hours of a bleeding stroke. The goal is to stop the bleeding and improve recovery at 90 days. About 350 adults aged 18-80 with a specific type of brain bleed are being recruited. The drug is compared to s…
Phase: PHASE3 • Sponsor: Joseph Broderick, MD • Aim: Disease control
Last updated May 26, 2026 06:45 UTC